RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study

Background Optimum dose ratios of rimabotulinumtoxinB (BTX‐B) and onabotulinumtoxinA (BTX‐A) have not been determined for forehead wrinkles. Objective To compare the efficacy and safety of BTX‐B and BTX‐A for the treatment of forehead lines. Methods Twenty‐two women (mean age, 40 years) with symm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2013-01, Vol.27 (1), p.e1-e7
Hauptverfasser:	Lee, D.H., Kang, S.M., Feneran, A., Youn, C.S., Kim, J.K., Cho, S., Won, C.H., Chang, S.E., Lee, M.W., Choi, J.H., Moon, K.C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Botulinum Toxins - adverse effects Botulinum Toxins - therapeutic use Botulinum Toxins, Type A - adverse effects Botulinum Toxins, Type A - therapeutic use Dose-Response Relationship, Drug Drug Administration Schedule Esthetics Facial Muscles - drug effects Female Forehead Humans Injections, Intramuscular Korea Middle Aged Patient Satisfaction Pilot Projects Prospective Studies Risk Assessment Single-Blind Method Skin Aging - drug effects Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!